ALPHA TAU MEDICAL LTD-CL A

DRTS05 Dec 2024
Healthcare
$3
0.00 (-0.33%)
Lowest Today
$3
Highest Today
$3.02
Today’s Open
$3
Prev. Close
$3.01
52 Week High
$3.4
52 Week Low
$1.75
To Invest in ALPHA TAU MEDICAL LTD-CL A

ALPHA TAU MEDICAL LTD-CL A

Healthcare
DRTS05 Dec 2024
0.00 (-0.33%)
1M
3M
6M
1Y
5Y
Low
$3
Day’s Range
High
$3.02
3
52 Week Low
$1.75
52-Week Range
52 Week High
$3.4
1.75
1 Day
-
1 Week
+2.73%
1 month return
+33.33%
3 month return
+33.33%
6 month return
+17.18%
1 Year return
-5.06%
3 Years return
-69.72%
5 Years return
-
10 Years return
-
Institutional Holdings
Easterly Investment Partners.
0.44
Hoylecohen, LLC
0.38
HighTower Advisors, LLC
0.33
Satovsky Asset Management LLC
0.08
Private Advisor Group, LLC
0.07
Morgan Stanley - Brokerage Accounts
0.06
Mariner Wealth Advisors LLC
0.06

Market Status

Fundamentals
Market Cap
211.71 mln
PB Ratio
3.05
PE Ratio
0
Enterprise Value
159.05 mln
Total Assets
107.39 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Organisation
ALPHA TAU MEDICAL LTD-CL A
Employees
121
Industry
Biotechnology
CEO
Mr. Uzi  Sofer
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step